Adeshwar Meditex Ltd Stock Price Today (NSE: ADESHWAR)
Adeshwar Meditex Ltd
Fundamental Score
Adeshwar Meditex Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Adeshwar Meditex Ltd share price today is ₹16.98, up +0.00% on NSE/BSE as of 30 March 2026. Adeshwar Meditex Ltd (ADESHWAR) is a Small-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹25.54 (Cr). The 52-week high for ADESHWAR share price is ₹21.80 and the 52-week low is ₹13.30. At a P/E ratio of 12.34x, ADESHWAR is currently trading below its industry average P/E of 45.95x. The company has a Return on Equity (ROE) of 5.51% and a debt-to-equity ratio of 0.16.
Adeshwar Meditex Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Adeshwar Meditex Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Adeshwar Meditex Share Price: A Conservative Value Investor's Perspective
The healthcare research, analytics, and technology sector is experiencing rapid growth, fueled by increasing demand for personalized medicine and efficient drug discovery. However, a conservative value investor prioritizes capital safety and a margin of safety. This analysis focuses on the Adeshwar Meditex share price, currently at ₹21.0, through that lens. We are conducting a fundamental audit.
Adeshwar Meditex Ltd. trades at a PE of 12.34. While seemingly attractive, this must be viewed in the context of its Return on Capital Employed (ROCE) of 8.27%. ROCE is a critical metric for assessing profitability and efficiency. It reveals how effectively the company utilizes capital to generate profits. An 8.27% ROCE, in my opinion, is not particularly high.
A company's ROCE directly impacts its economic moat. A strong moat protects a business from competitors and allows it to generate sustainable profits. A higher ROCE typically indicates a wider moat. In Adeshwar Meditex's case, the 8.27% ROCE suggests a potentially limited moat. The company might struggle to maintain its competitive advantage if new entrants or existing players offer superior products or services.
Comparing Adeshwar Meditex to its peers, such as
NOVELIX PHARMACEUTICALS LIMITE, is important. Management quality is also paramount. A thorough investigation into corporate governance, insider ownership, and past capital allocation decisions is necessary. The management team's experience and track record significantly impact the company's long-term success. While this analysis does not make specific recommendations, this suggests avenues for further investigation.This financial analysis is part of a comprehensive 80-parameter fundamental audit of Adeshwar Meditex Ltd., verified by Sweta Mishra. It should be considered observational. Investors should conduct their own due diligence before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Adeshwar Meditex Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ADESHWAR across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 12.34 vs Industry: 45.95)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.16)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (5.25x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (57.55%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (5.51%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.27%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-18.89%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-26.50%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-19.37% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-1.36% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Adeshwar Meditex Ltd Financial Statements
Comprehensive financial data for Adeshwar Meditex Ltd including income statement, balance sheet and cash flow
About ADESHWAR (Adeshwar Meditex Ltd)
Adeshwar Meditex Ltd is a pioneering force in the healthcare landscape, specializing in the research, analytics, and technological advancements surrounding advanced wound care and ...infection control. The company dedicates itself to understanding the intricate biological processes involved in wound healing, leveraging data-driven insights to create innovative solutions that promote faster recovery and minimize patient discomfort. Adeshwar's research division delves into the complexities of microbial resistance and the efficacy of various therapeutic agents, constantly seeking to improve the performance and safety of its product portfolio. By integrating cutting-edge technology with a deep understanding of clinical needs, Adeshwar strives to redefine the standards of wound management, empowering healthcare professionals with effective tools to deliver optimal patient outcomes. The heart of Adeshwar Meditex lies in its commitment to developing next-generation wound care solutions. They achieve this by integrating advanced biomaterials with sophisticated drug delivery systems. This approach allows for precise control over the healing process, tailoring treatments to individual patient needs. The company's analytical capabilities allow them to evaluate the effectiveness of these solutions. This includes assessing their impact on infection rates, scar formation, and overall healing time. Their team of scientists and engineers works tirelessly to translate groundbreaking research into practical applications, fostering a continuous cycle of innovation that addresses the evolving challenges of wound care. Adeshwar Meditex's technological prowess extends beyond product development. It encompasses a comprehensive suite of digital tools designed to enhance the patient experience and improve healthcare delivery. The company is actively exploring the use of artificial intelligence and machine learning to personalize wound care plans, predict potential complications, and optimize treatment protocols. Additionally, Adeshwar is committed to fostering collaboration and knowledge sharing within the healthcare community. This is achieved by providing healthcare professionals with access to valuable data and insights. Ultimately, Adeshwar seeks to be a catalyst for positive change in the world of wound care and infection control.
Company Details
Key Leadership
ADESHWAR Share Price: Frequently Asked Questions
What is the current share price of Adeshwar Meditex Ltd (ADESHWAR)?
As of 30 Mar 2026, 11:00 am IST, Adeshwar Meditex Ltd share price is ₹16.98. The ADESHWAR stock has a market capitalisation of ₹25.54 (Cr) on NSE/BSE.
Is ADESHWAR share price Overvalued or Undervalued?
ADESHWAR share price is currently trading at a P/E ratio of 12.34x, compared to the industry average of 45.95x. Based on this relative valuation, the Adeshwar Meditex Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of ADESHWAR share price?
The 52-week high of ADESHWAR share price is ₹21.80 and the 52-week low is ₹13.30. These values are updated daily from NSE/BSE price data.
What factors affect the Adeshwar Meditex Ltd share price?
Key factors influencing ADESHWAR share price include quarterly earnings growth (Sales Growth: -26.50%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Adeshwar Meditex Ltd a good stock for long-term investment?
Adeshwar Meditex Ltd shows a 5-year Profit Growth of -1.36% and an ROE of 5.51%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.16 before investing in ADESHWAR shares.
How does Adeshwar Meditex Ltd compare with its industry peers?
Adeshwar Meditex Ltd competes with major peers in the Healthcare Research, Analytics & Technology. Investors should compare ADESHWAR share price P/E of 12.34x and ROE of 5.51% against the industry averages to determine competitive standing.
What is the P/E ratio of ADESHWAR and what does it mean?
ADESHWAR share price has a P/E ratio of 12.34x compared to the industry average of 45.95x. Investors pay ₹12 for every ₹1 of annual earnings.
How is ADESHWAR performing according to Bull Run's analysis?
ADESHWAR has a Bull Run fundamental score of 29.2/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ADESHWAR belong to?
ADESHWAR operates in the Healthcare Research, Analytics & Technology industry. This classification helps understand the competitive landscape and sector-specific trends affecting Adeshwar Meditex Ltd share price.
What is Return on Equity (ROE) and why is it important for ADESHWAR?
ADESHWAR has an ROE of 5.51%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Adeshwar Meditex Ltd generates profits from shareholders capital.
How is ADESHWAR debt-to-equity ratio and what does it indicate?
ADESHWAR has a debt-to-equity ratio of 0.16, which indicates conservative financing with low financial risk.
What is ADESHWAR dividend yield and is it a good dividend stock?
ADESHWAR offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Adeshwar Meditex Ltd shares.
How has ADESHWAR share price grown over the past 5 years?
ADESHWAR has achieved 5-year growth rates of: Sales Growth 8.33%, Profit Growth -1.36%, and EPS Growth -19.37%.
What is the promoter holding in ADESHWAR and why does it matter?
Promoters hold 57.55% of ADESHWAR shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Adeshwar Meditex Ltd.
What is ADESHWAR market capitalisation category?
ADESHWAR has a market capitalisation of ₹26 crores, placing it in the Small-cap category.
How volatile is ADESHWAR stock?
ADESHWAR has a beta of N/A. A beta > 1 suggests the Adeshwar Meditex Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ADESHWAR operating profit margin trend?
ADESHWAR has a 5-year average Operating Profit Margin (OPM) of 6.09%, indicating the company's operational efficiency.
How is ADESHWAR quarterly performance?
Recent quarterly performance shows Adeshwar Meditex Ltd YoY Sales Growth of -26.50% and YoY Profit Growth of -18.89%.
What is the institutional holding pattern in ADESHWAR?
ADESHWAR has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Adeshwar Meditex Ltd stock.